Security key
22053A107
Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (QNCX)
CUSIP: 22053A107
Q1 2020 13F Holders as of 31 Mar 2020
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 11,450,501
- Total 13F value
- $522,757,976
- Share change
- +860,556
- SEC-reported price per share
- $45.61
- Number of holders
- 65
- Value change
- +$39,593,805
- Number of buys
- 42
- Number of sells
- 15
- Shares outstanding
- 60,216,782
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2020
Institutions
65
Top holders
10
QNCX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Quince Therapeutics, Inc. SEC filings
Quince Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22053A107
Recent filing periods:
Ownership snapshot
Top reported holders of QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EPIQ Capital Group, LLC
Disclosed value leader
EPIQ Capital Group, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2019
13F
Lead comparable stake: 5.2%
Showing 1-6 of 15 holder rows.
Quick read
EPIQ Capital Group, LLC leads the comparable SEC ownership view at 5.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EPIQ Capital Group, LLC's linked filing trail.
Comparable ownership
Top 5
EPIQ Capital Group, LLC
5.2%
Capital Research Global Investors
4.1%
SC US (TTGP), LTD.
1.7%
Capital International Investors
1.6%
BlackRock Finance, Inc.
0.97%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EPIQ Capital Group, LLC |
13F
Company
|
5.2%
|
$176,470,000
3,143,394 shares
|
— | 31 Dec 2019 |
| Capital Research Global Investors |
13F
Company
|
4.1%
|
$137,145,000
2,442,914 shares
|
— | 31 Dec 2019 |
| SC US (TTGP), LTD. |
13F
Company
|
1.7%
|
$58,405,000
1,040,343 shares
|
— | 31 Dec 2019 |
| Capital International Investors |
13F
Company
|
1.6%
|
$53,778,000
957,925 shares
|
— | 31 Dec 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
0.97%
|
$32,876,000
585,619 shares
|
— | 31 Dec 2019 |
| Capital World Investors |
13F
Company
|
0.95%
|
$32,130,000
572,327 shares
|
— | 31 Dec 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
65
Shares
11,450,501
Rows available
65
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2020 vs Q1 2020 Across Filers
Q1 2020 holders
65
Q1 2020 holders
65
Holder diff
0
| Investor | Q1 2020 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q1 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend